Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin

Microbial Cell Factories

Volumn 10, Issue , 2011, Pages

  Pleckaityte, Milda ^a   Zvirbliene, Aurelija ^a   Sezaite, Indre ^a   Gedvilaite, Alma ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Recombinant antibodies; Vaginolysin; Virus like particles

Indexed keywords

HEXAHISTIDINE; IMMUNOGLOBULIN G1; NEUTRALIZING ANTIBODY; PROTEIN VP1; PROTEIN VP2; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; VAGINOLYSIN; VIRULENCE FACTOR; BACTERIAL PROTEIN; BACTERIAL TOXIN; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; PERFORIN; VAGINOLYSIN, GARDNERELLA VAGINALIS; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CYTOLYSIS; ERYTHROCYTE; GARDNERELLA VAGINALIS; HELA CELL; HYBRIDOMA CELL CULTURE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; SEQUENCE ANALYSIS; VIRUS LIKE AGENT; YEAST; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; POLYOMA VIRUS; PROTEIN ENGINEERING; SERODIAGNOSIS;

GARDNERELLA; HAMSTER POLYOMAVIRUS; SACCHAROMYCES CEREVISIAE;

ANTIBODIES, NEUTRALIZING; BACTERIAL PROTEINS; BACTERIAL TOXINS; GARDNERELLA VAGINALIS; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; NEUTRALIZATION TESTS; PERFORIN; POLYOMAVIRUS; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE; SINGLE-CHAIN ANTIBODIES; VIRAL PROTEINS;

EID: 83455169221     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-10-109     Document Type: Article

References (40)

1. Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 2010, 9:767-774. 10.1038/nrd3229, 20811384.
2. Hagemeyer CE, von Zur Muhlen C, von Elverfeldt D, Peter K. Single-chain antibodies as diagnostic tools and therapeutic agents. Thromb Haemost 2009, 101:1012-1019.
3. de Marco A. Biotechnological applications of recombinant single-domain antibody fragments. Microb Cell Fact 2011, 10:44. 10.1186/1475-2859-10-44, 3123181, 21658216.
4. Hudson PJ. Recombinant antibody fragments. Curr Opin Biotechnol 1998, 9:395-402. 10.1016/S0958-1669(98)80014-1, 9720265.
5. Kim JK, Tsen MF, Ghetie V, Ward ES. Catabolism of the murine IgG1 molecule: evidence that both CH2-CH3 domain interfaces are required for persistence of IgG1 in the circulation of mice. Scand J Immunol 1994, 40:457-465. 10.1111/j.1365-3083.1994.tb03488.x, 7939418.
6. Hudson PJ, Kortt AA. High avidity scFv multimers; diabodies and triabodies. J Immunol Methods 1999, 231:177-189. 10.1016/S0022-1759(99)00157-X, 10648937.
7. Powers DB, Amersdorfer P, Poul M, Nielsen UB, Shalaby MR, Adams GP, Weiner LM, Marks JD. Expression of single-chain Fv-Fc fusions in Pichia pastoris. J Immunol Methods 2001, 251:123-135. 10.1016/S0022-1759(00)00290-8, 11292488.
8. Kenanova V, Olafsen T, Crow DM, Sundaresan G, Subbarayan M, Carter NH, Ikle DN, Yazaki PJ, Chatziioannou AF, Gambhir SS, Williams LE, Shively JE, Colcher D, Raubitschek AA, Wu AM. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res 2005, 65:622-631.
9. Moutel S, El Marjou A, Vielemeyer O, Nizak C, Benaroch P, Dübel S. A multi-Fc-species system for recombinant antibody production. BMC Biotechnol 2009, 9:14. 10.1186/1472-6750-9-14, 2654441, 19245715.
10. Andersen DC, Reily DE. Production technologies for monoclonal antibodies and their fragments. Curr Opin Biotechnol 2004, 15:456-462. 10.1016/j.copbio.2004.08.002, 15464378.
11. Schoonooghe S, Kaigorodov V, Zawisza M, Dumolyn C, Haustraete J, Grooten J, Mertens N. Efficient production of human bivalent and trivalent anti-MUC1 Fab-scFv antibodies in Pichia pastoris. BMC Biotechnol 2009, 9:70. 10.1186/1472-6750-9-70, 2736937, 19671134.
12. Gasser B, Maurer M, Gach J, Kunert R, Mattanovich D. Engineering of Pichia pastoris for improved production of antibody fragments. Biotechnol Bioeng 2006, 94:353-361. 10.1002/bit.20851, 16570317.
13. Hood EE, Woodard SL, Horn ME. Monoclonal antibody manufacturing in transgenic plants-myths and realities. Curr Opin Biotechnol 2002, 13:630-635. 10.1016/S0958-1669(02)00351-8, 12482526.
14. Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V, Gleba Y. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci USA 2006, 103:14701-14706. 10.1073/pnas.0606631103, 1566189, 16973752.
15. Huang Z, Phoolcharoen W, Lai H, Piensook K, Cardineau G, Zeitlin L, Whaley KJ, Arntzen CJ, Mason HS, Chen Q. High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnol Bioeng 2010, 106:9-17. 2905544, 20047189.
16. Jeong KJ, Jang SH, Velmurugan N. Recombinant antibodies: engineering and production in yeast and bacterial hosts. Biotechnol J 2011, 6:16-27. 10.1002/biot.201000381, 21170983.
17. Shusta EV, Raines RT, Pluckthun A, Wittrup KD. Increasing the secretory capacity of Saccharomyces cerevisiae for production of single chain antibody fragments. Nat Biotechnol 1998, 16:773-777. 10.1038/nbt0898-773, 9702778.
18. Zvirbliene A, Pleckaityte M, Lasickiene R, Kucinskaite-Kodze I, Zvirblis G. Production and characterization of monoclonal antibodies against vaginolysin: mapping of a region critical for its cytotoxic activity. Toxicon 2010, 56:19-28. 10.1016/j.toxicon.2010.03.007, 20298711.
19. Tweten RK. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect Immun 2005, 73:6199-6209. 10.1128/IAI.73.10.6199-6209.2005, 1230961, 16177291.
20. Rosado CJ, Kondos S, Bull TE, Kuiper MJ, Law RH, Buckle AM, Voskoboinik I, Bird PI, Trapani JA, Whisstock JC, Dunstone MA. The MACPF/CDC family of pore-forming toxins. Cell Microbiol 2008, 10:1765-1774. 10.1111/j.1462-5822.2008.01191.x, 2654483, 18564372.
21. Randis TM, Kulkarni R, Aquilar JL, Ratner AJ. Antibody-based detection and inhibition of vaginolysin, the Gardnerella vaginalis cytolysin. PLoS One 2009, 4:e5207. 10.1371/journal.pone.0005207, 2666159, 19370149.
22. Sasnauskas K, Buzaite O, Vogel F, Jandrig B, Razanskas R, Staniulis J, Scherneck S, Krüger DH, Ulrich R. Yeast cells allow the high-level expression and formation of polyomavirus-like particles. Biol Chem 1999, 380:381-386. 10.1515/BC.1999.050, 10223341.
23. Porro D, Sauer M, Branduardi P, Mattanovich D. Recombinant protein production in yeasts. Mol Biotechnol 2005, 31:245-259. 10.1385/MB:31:3:245, 16230775.
24. Gasser B, Mattanowitch D. Antibody production with yeasts and filamentous fungi: on the road to large scale?. Biotechnol Lett 2007, 29:201-212. 10.1007/s10529-006-9237-x, 17120087.
25. Ren F, Li BC, Zhang NN, Cao M, Dan WB, Zhang SQ. Expression, purification and characterization of anti-BAFF antibody secreted from the Pichia pastoris. Biotechnol Lett 2008, 30:1075-1080. 10.1007/s10529-008-9657-x, 18259874.
26. Braren I, Greunke K, Umland O, Deckers S, Bredehorst R, Spillner E. Comparative expression of different antibody formats in mammalian cells and Pichia pastoris. Biotechnol Appl Biochem 2007, 47:205-214. 10.1042/BA20060170, 17373908.
27. Liu J, Wei D, Qian F, Zhou Y, Wang J, Ma Y, Han Z. pPIC9-Fc: a vector system for the production of single-chain Fv-Fc fusions in Pichia pastoris as detection reagents in vitro. J Biochem 2003, 134:911-917. 10.1093/jb/mvg222, 14769881.
28. Joosten V, Lokman C, van den Hondel CAMJJ, Punt PJ. The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microb Cell Fact 2003, 30(2):1.
29. Kauffman KJ, Pridgen EM, Doyle FJ, Dhurjati PS, Robinson AS. Decreased protein expression and intermittent recoveries in BiP levels result from cellular stress during heterologous protein expression in Saccharomyces cerevisiae. Biotechnol Prog 2002, 18:942-950. 10.1021/bp025518g, 12363344.
30. Frenken L, van Tuijl E, Bos JW, Müller WH, Verkleij AJ, Verrips CT. ScFv antibody fragments produced in Saccharomyces cerevisiae accumulate in the endoplasmic reticulum and the vacuole. Biological membranes: structure biogenesis and dynamics (Edited by: NATO ASI Series) 1994, H82:223-236. Springer-Verlag Berlin, Heidelberg.
31. Liddington RC, Yan Y, Moulai J, Sahli R, Benjamin TL, Harrison SC. Structure of simian virus 40 at 3.8 Å resolution. Nature 1991, 354:278-284. 10.1038/354278a0, 1659663.
32. Stehle T, Yan Y, Benjamin TL, Harrison SC. Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 1994, 369:160-163. 10.1038/369160a0, 8177322.
33. Griffith JP, Griffith DL, Rayment I, Murakami WT, Caspar DL. Inside polyomavirus at 25-Å resolution. Nature 1992, 355:652-4. 10.1038/355652a0, 1311415.
34. Pumpens P, Grens E. Artificial genes for chimeric virus-like particles. Artificial DNA: Methods and Applications 2002, 249-327. Boca Raton: CRC Press LLC, Khudyakov YE, Fields HA.
35. Sasnauskas K, Bulavaite A, Hale A, Jin L, Gedvilaite A, Dargeviciute A, Bartkeviciute D, Zvirblienė A, Staniulis J, Brown DWG, Ulrich R. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae. Intervirology 2002, 45:471-482.
36. Gedvilaite A, Frommel C, Sasnauskas K, Burkhard M, Ozel M, Behrsing O, Staniulis J, Jandrig B, Scherneck S, Ulrich R. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster major capsid protein. Virology 2000, 273:21-35. 10.1006/viro.2000.0392, 10891404.
37. Gedvilaite A, Zvirbliene A, Staniulis J, Sasnauskas K, Krüger DH, Ulrich R. Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice. Viral Immunol 2004, 17:51-68. 10.1089/088282404322875458, 15018662.
38. Dorn DC, Lawatscheck R, Zvirbliene A, Aleksaite E, Pecher G, Sasnauskas K, Ozel M, Raftery M, Schönrich G, Ulrich RG, Gedvilaite A. Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope. Viral Immunol 2008, 21:12-27. 10.1089/vim.2007.0085, 18355119.
39. Slibinskas R, Samuel D, Gedvilaite A, Staniulis J, Sasnauskas K. Synthesis of the measles virus nucleoprotein in yeast Pichia pastoris and Saccharomyces cerevisiae. J Biotechnol 2004, 107:115-124. 10.1016/j.jbiotec.2003.10.018, 14711495.
40. Sambrook J, Russell DW. Molecular cloning, A Laboratory Manual 2001, Cold Spring Harbour, Cold Spring Harbor Press.